quality of life

The growing use of effective treatment strategies for metastatic cancer in the brain has not been documented in certain patient populations.
Young patients with head and neck sarcoma treated with proton beam therapy had similar outcomes with less of an impact on quality of life as those treated with traditional photon radiation.
In patients with HER2-positive metastatic gastric cancer, subcutaneous administration of a common therapy results in significant time savings for health care providers as well as reduced costs.
The American Society of Clinical Oncology has released new guideline recommendations for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
A comparative effectiveness study analyzed response to anemia supportive treatment for patients with multiple myeloma or lymphoma.
A multikinase inhibitor used in the second-line setting for hepatocellular carcinoma offers limited increases in quality-adjusted life years.
A novel, theoretically–based psychosocial intervention improves the fear of cancer recurrence among survivors 6 months post-therapy.
Halting adjuvant endocrine therapy for ER-positive breast cancer after 5 years does not reduce the risk of cancer recurrence in the long-term.
A recent study assessed whether neoadjuvant chemotherapy is superior to primary debulking surgery with regard to mortality and quality of life for patients with advanced epithelial ovarian cancer.